Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination for herpes simplex genitalis.

T Nasemann, S W Wassilew

    The British Journal of Venereal Diseases
    |April 1, 1979
    PubMed
    Summary

    Type-specific vaccines for genital herpes (herpes simplex genitalis) show promise. Treatment with the type 2 vaccine improved disease course and extended remission periods, especially when combined with immunoglobulin for severe cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib.

    Deutsche medizinische Wochenschrift (1946)·2009
    Same author

    [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].

    MMW Fortschritte der Medizin·2006
    Same author

    [Varicella-zoster virus infections--2: Zoster pain -- therapy and prevention].

    MMW Fortschritte der Medizin·2006
    Same author

    [Varicella-zoster virus infections].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2004
    Same author

    [4th International Conference on Varicella, Herpes Zoster and Postherpetic Neuralgia (PHN). 3-5 March 2001, La Jolla, California, USA].

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2002
    Same author

    Early diagnosis of herpes zoster by polymerase chain reaction.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2002

    Area of Science:

    • Virology
    • Immunology
    • Dermatology

    Background:

    • Genital herpes simplex (herpes simplex genitalis) is a recurrent viral infection.
    • Limited effective treatments exist for managing recurrent or severe outbreaks.

    Purpose of the Study:

    • To evaluate the efficacy of type-specific heat-inactivated herpes simplex hominis virus vaccines for treating genital herpes.
    • To assess the impact of vaccine therapy on disease recurrence and severity.

    Main Methods:

    • Administration of type 1 or type 2 heat-inactivated herpes simplex hominis virus vaccines.
    • Concurrent use of vaccine and immunoglobulin concentrates in severe cases.
    • Monitoring of clinical disease course, eruption-free intervals, antibody titers, and lymphocyte stimulation.

    Main Results:

    • Treatment with the type 2 vaccine improved the clinical course of recurrent genital herpes.
    • The eruption-free interval was extended in patients receiving the type 2 vaccine.
    • Combined vaccine and immunoglobulin therapy improved outcomes in severe and persistent genital herpes cases.
    • Antibody titers and in-vitro lymphocyte responses remained stable during vaccination.

    Conclusions:

    • Type-specific herpes simplex hominis virus vaccines are a viable treatment option for genital herpes.
    • Vaccine therapy, particularly type 2, can effectively manage recurrent disease and prolong remission.
    • Combination therapy with immunoglobulin offers benefits for severe and chronic genital herpes cases.

    Related Experiment Videos